A Disposable Nitinol Memory Alloy Anal Fistula Clip (AFC) for the Treatment of Cryptoglandular Fistula-In-Ano: a Prospective, Randomized, Controlled Study With Short-Term Follow-Up
verfasst von:
Yaxian Wang, Yanlan Wu, Yehuang Wang, Bin Jiang, Chungen Zhou, Yang Zhang
Presented at a conference on the Application of Minimally Invasive Technology in Anorectal Diseases, Lianyungang City, Jiangsu Province, China, August 15, 2020.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Introduction
Surgical treatment of fistula-in-ano is an ongoing challenge and has led to the design of the disposable shape memory nitinol anal fistula clip (AFC) (Fig. 1). We conducted a prospective clinical study to evaluate the efficacy and safety of the AFC for cryptoglandular fistula-in-ano treatment compared with the endorectal advancement flap (ERAF).
×
Methods
Fifty-one patients with cryptoglandular fistula-in-ano were enrolled between January 2019 and January 2020 in the National Colorectal Disease Center of Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine. The patients were randomly assigned for management with either AFC or ERAF (Fig. 2). The primary endpoint was fistula healing after proctology clip placement assessed by clinical examination (at weeks 6 and 12 and month 6) and endorectal ultrasonography (ERUS) (at week 6). The secondary endpoints included reduced pain score (Visual Analog Scale, VAS) and incontinence (Wexner) score at follow-up. Safety evaluation based on adverse events was also monitored.
×
Anzeige
Results
Of the 51 patients, 25 were included in the AFC group and 26 in the ERAF group. There were no significant differences in selected features between the two groups at baseline.
The fistula healing rates within the AFC group and ERAF group at week 6 were 48.0% (12/25) and 46.2% (12/26), respectively, with no significant difference between them (p = 1.0). At week 12, the healing rates between the AFC group (88.0%, 22/25) and ERAF group (69.2%, 18/26) did not differ significantly (p = 0.1), while at month 6, there was a significant difference (p = 0.021) between the AFC (92.0%, 23/25) and the ERAF (65.4%, 17/26) groups. Furthermore, at month 6, the trans-sphincteric fistula healing rate differed significantly (p = 0.047) between the AFC (100.0%, 20/20) and the ERAF (80.0%, 15/20) groups (Table 1). There was no significant difference in the VAS and Wexner scores between the two groups. Fewer adverse events were observed in the AFC group (32.0%) than in the ERAF group (53.9%), although the difference was nonsignificant.
Table 1
Primary endpoint at month 6
Patients
AFC
ERAF
Analysis
Total
healed
%
Total
healed
%
Difference
95%CI
p value
All cases
25
23
92.0
26
17
65.4
26.62
3.83–46.63
0.021
Subgroup analysis
Trans-sphincteric
20
20
100.0
20
15
80.0
20.00
3.78–46.87
0.047
Supra-sphincteric
5
3
60.0
6
2
33.3
26.67
− 25.37–63.50
0.570
Discussion
Although ERAF does not destroy the anal sphincter and has a moderate success rate, postoperative recurrence and incontinence represent challenges.1,2 The AFC exerts constant pressure on the internal opening resulting in permanent and dynamic closure.
In the AFC group, one clip fell off on its own on day 10, while the rest were removed by cutting the lateral hinges of the clip with the special AFC clip cutter at about 3.8 weeks (range, 3–4 weeks) without complaint. Six clips needed to be removed under abnormal circumstances. In the ERAF group, eight patients still complained of persistent secretions around the anus at week 12, and five received a second operation. In this study, six cases in the two groups retained a narrow tract without secretion while the internal opening was closed. The key to success was the capture of sufficient tissue volume. If sufficient external drainage cannot be guaranteed, inflammatory complications are inevitable.
Anzeige
The main limitations of this study were the small sample size and the short follow-up time. Nevertheless, the study provides evidence for the safety and efficacy of AFC in the treatment of cryptoglandular fistula-in-ano. AFC is an innovative contribution to minimally invasive sphincter-preserving technology.
Acknowledgements
We express our sincere appreciation to the patients who participated in this study.
Declarations
Ethics Approval and Consent to Participate
All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the ethics committee of Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine (Nanjing, China). Written informed consent was obtained from all study subjects.
Consent for Publication
Consent for publication was obtained from all study subjects and their guardians by signing an informed consent form during screening. All the authors consent to publish the paper.
Competing Interests
The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.
Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!
A Disposable Nitinol Memory Alloy Anal Fistula Clip (AFC) for the Treatment of Cryptoglandular Fistula-In-Ano: a Prospective, Randomized, Controlled Study With Short-Term Follow-Up
verfasst von
Yaxian Wang Yanlan Wu Yehuang Wang Bin Jiang Chungen Zhou Yang Zhang
Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.
Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.
Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.
Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.